IL-7 restores lymphocyte functions in septic patients

Journal of Immunology

Volumn 189, Issue 10, 2012, Pages 5073-5081

  Venet, Fabienne ^a,b   Foray, Anne Perrine ^a   Villars Méchin, Astrid ^a   Malcus, Christophe ^a   Poitevin Later, Françoise ^a   Lepape, Alain ^b,c   Monneret, Guillaume ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 7 RECEPTOR; RECOMBINANT INTERLEUKIN 7; STAT5 PROTEIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEPSIS; TREND STUDY;

AGED; AGED, 80 AND OVER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-7; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; SEPSIS; STAT5 TRANSCRIPTION FACTOR;

EID: 84868549577     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202062     Document Type: Article

References (25)

1. Hotchkiss, R. S., C. M. Coopersmith, J. E. McDunn, and T. A. Ferguson. 2009. The sepsis seesaw: tilting toward immunosuppression. Nat. Med. 15: 496-497.
2. Hotchkiss, R. S., and S. Opal. 2010. Immunotherapy for sepsis\a new approach against an ancient foe. N. Engl. J. Med. 363: 87-89.
3. Monneret, G., F. Venet, A. Pachot, and A. Lepape. 2008. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol. Med. 14: 64-78.
4. Mackall, C. L., T. J. Fry, and R. E. Gress. 2011. Harnessing the biology of IL-7 for therapeutic application. Nat. Rev. Immunol. 11: 330-342.
5. Munier, M. L., and A. D. Kelleher. 2007. Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol. Cell Biol. 85: 6-15.
6. Lundström, W., N. M. Fewkes, and C. L. Mackall. 2012. IL-7 in human health and disease. Semin. Immunol. 24: 218-224.
7. Sportès, C., F. T. Hakim, S. A. Memon, H. Zhang, K. S. Chua, M. R. Brown, T. A. Fleisher, M. C. Krumlauf, R. R. Babb, C. K. Chow, et al. 2008. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J. Exp. Med. 205: 1701-1714.
8. Unsinger, J., C. A. Burnham, J. McDonough, M. Morre, P. S. Prakash, C. C. Caldwell, W. M. Dunne, Jr., and R. S. Hotchkiss. 2012. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J. Infect. Dis. 206: 606-616.
9. Kasten, K. R., P. S. Prakash, J. Unsinger, H. S. Goetzman, L. G. England, C. M. Cave, A. P. Seitz, C. N. Mazuski, T. T. Zhou, M. Morre, et al. 2010. Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gdT-cell IL-17 production in a murine model of sepsis. Infect. Immun. 78: 4714-4722.
10. Unsinger, J., M. McGlynn, K. R. Kasten, A. S. Hoekzema, E. Watanabe, J. T. Muenzer, J. S. McDonough, J. Tschoep, T. A. Ferguson, J. E. McDunn, et al. 2010. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184: 3768-3779.
11. Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31: 1250-1256.
12. Crawley, A. M., S. Faucher, and J. B. Angel. 2010. Soluble IL-7Ra (sCD127) inhibits IL-7 activity and is increased in HIV infection. J. Immunol. 184: 4679-4687.
13. Monneret, G., A. Lepape, N. Voirin, J. Bohé, F. Venet, A. L. Debard, H. Thizy, J. Bienvenu, F. Gueyffier, and P. Vanhems. 2006. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 32: 1175-1183.
14. -) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 35: 678-686.
15. Venet, F., F. Davin, C. Guignant, A. Larue, M. A. Cazalis, R. Darbon, C. Allombert, B. Mougin, C. Malcus, F. Poitevin-Later, et al. 2010. Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 34: 358-363.
16. Crawley, A. M., and J. B. Angel. 2012. The influence of HIV on CD127 expression and its potential implications for IL-7 therapy. Semin. Immunol. 24: 231-240.
17. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
18. Boomer, J. S., K. To, K. C. Chang, O. Takasu, D. F. Osborne, A. H. Walton, T. L. Bricker, S. D. Jarman, II, D. Kreisel, A. S. Krupnick, et al. 2011. Immu-nosuppression in patients who die of sepsis and multiple organ failure. JAMA 306: 2594-2605.
19. Skrupky, L. P., P. W. Kerby, and R. S. Hotchkiss. 2011. Advances in the management of sepsis and the understanding of key immunologic defects. Anes-thesiology 115: 1349-1362.
20. Meakins, J. L., J. B. Pietsch, O. Bubenick, R. Kelly, H. Rode, J. Gordon, and L. D. MacLean. 1977. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann. Surg. 186: 241-250.
21. Venet, F., O. Filipe-Santos, A. Lepape, C. Malcus, F. Poitevin-Later, A. Grives, N. Plantier, N. Pasqual, and G. Monneret. 2012. Decreased T cell repertoire diversity in sepsis: a preliminary study. Crit. Care Med. In press.
22. Heininger, A., H. Haeberle, I. Fischer, R. Beck, R. Riessen, F. Rohde, C. Meisner, G. Jahn, A. Koenigsrainer, K. Unertl, and K. Hamprecht. 2011. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit. Care 15: R77.
23. Kalil, A. C., and D. F. Florescu. 2009. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit. Care Med. 37: 2350-2358.
24. Huang, X., F. Venet, Y. L. Wang, A. Lepape, Z. Yuan, Y. Chen, R. Swan, H. Kherouf, G. Monneret, C. S. Chung, and A. Ayala. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. USA 106: 6303-6308.
25. + regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. 31: 2068-2071.